Fentanyl Bill Signed By Trump Would Also ‘Streamline Research’ On Schedule I Drugs Like Marijuana, Congressional Analysts Say

Marijuana Moment
By Kyle JaegerAug 8, 2025, 9:58 am251 ptsTop
A bill signed into law by President Donald Trump last month banning fentanyl analogues would also make a series of changes to current laws that have restricted research into Schedule I drugs like marijuana and psychedelics, congressional analysts say. In a report published last week—shortly after Trump gave…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Cresco Labs Closes $325 Million Senior Secured Term Loan Refinancing 80

MediPharm Labs reports revenue growth Q2 2025, driven by international sales 80

Weak Michigan Cannabis Sales Again in July 79

New Jersey Officials Share Tips For Marijuana Use At Newly Opened Consumption Lounges 77

New York allowed pot shops to open too close to schools. Now they might have to move 75

High Tide to Become Major Player in German Medical Cannabis Market Through €27.2 Million Acquisition 74

Cannabis Investors Should Consider REITs 70

"Great Things about Medical" - Trump & Rescheduling Cannabis 70

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.